Obtaining a patent grants exclusive rights, but working the invention and maintaining Form 27 compliance is equally important in the Indian patent system.
A patent is not a silent paper monopoly but a living promise of progress; Form 27 is the pulse that proves an invention is working for the benefit of the nation.
Form 27 represents a unique compliance instrument within the Indian patent regime, reflecting the legislature’s insistence that patent protection must translate into real-world technological and economic benefit, rather than remain a paper monopoly. Unlike jurisdictions where patent rights are largely detached from post-grant accountability, Indian patent law adopts a more interventionist approach by requiring patentees and licensees to periodically disclose whether their inventions are actually being put to use within the country. Form 27 is the procedural expression of this philosophy. At its core, Form 27 is not concerned with the validity of a patent, but with its functional relevance. It seeks to answer a fundamental policy question: Has the patented invention moved beyond exclusive ownership and entered the stream of practical application? By compelling disclosure of working status, the law discourages passive patent holding, speculative hoarding, and strategic non-use of patented technologies that could otherwise serve public and industrial needs. The requirement to file Form 27 emerged from longstanding concerns that patents, particularly those held by large multinational entities, were often retained in India without meaningful domestic exploitation. Such practices risked limiting access to technology, suppressing local manufacturing, and undermining the broader objectives of innovation dissemination and economic development. Form 27, therefore, operates as a transparency and accountability mechanism, enabling the State to monitor whether exclusive rights are aligned with public interest considerations. From an industry perspective, the significance of Form 27 varies considerably. In sectors such as electronics, software-enabled technologies, and consumer manufacturing, the form is often treated as a routine compliance exercise, especially where import-based working or licensing models are prevalent. However, in highly regulated and socially sensitive sectors—most notably pharmaceuticals, biotechnology, and medical devices—Form 27 assumes far greater importance. In these industries, disclosures relating to working status may directly influence debates on access, pricing, availability, and even future regulatory or compulsory licensing actions.
Statutory Disclosure of the Commercial Working of Patented Inventions in India and the Role of Form 27
Section 146(2) of the Patents Act, 1970, read with Rule 131(1) of the Patents Rules, 2003, statutorily mandates patentees and licensees to furnish information to the Patent Office regarding the extent to which a patented invention has been commercially worked in India. This obligation is not procedural in nature but flows directly from the substantive scheme of the Act, which conditions the enjoyment of exclusive patent rights upon their effective utilisation within the Indian Territory. The rationale underlying this statutory provision is rooted in the Indian patent law’s rejection of patents as mere instruments of exclusion. The Act does not permit patents to be held solely for the purpose of blocking competition, delaying market entry, or preserving monopoly rents without corresponding commercial exploitation. Section 146(2) is designed to prevent the phenomenon of patent hoarding, wherein patentees secure exclusive rights but refrain from working the invention domestically, thereby restricting access to technology without delivering any tangible public or economic benefit. Form 27 plays a central role in enforcing this legislative intent by compelling patentees and licensees to periodically disclose whether the patented invention has been worked in India and, if not, to account for such non-working. The disclosure serves as an accountability mechanism, ensuring that patent rights are exercised in alignment with the objectives of the Act, particularly the promotion of technological dissemination, industrial development, and public access to inventions on reasonable terms.
Non-Disclosure of Patent Working and Its Consequences under the Compulsory Licensing Regime
Non-disclosure of patent working undermines the statutory framework that conditions the grant and continuation of patent rights upon their meaningful commercial exploitation in India. The obligation to disclose whether a patented invention is worked is central to ensuring that patent monopolies are not retained in isolation from their intended economic and public purpose. Where a patentee or licensee fails to disclose the working status of a patent, or furnishes false or misleading information, such non-compliance attracts legal consequences that extend beyond mere procedural default. The law treats disclosure as a mandatory duty, and its breach may result in penal action, including the imposition of fines and, in cases involving deliberate or wilful misrepresentation, exposure to criminal liability, including imprisonment. These penalties reflect the seriousness with which the legislature views transparency in the exercise of patent rights. More significantly, non-disclosure has substantive implications for the patentee’s exclusive rights under the compulsory licensing regime. The compulsory licensing framework is premised on the principle that patent protection cannot be sustained where the patented invention is not adequately worked or where the reasonable requirements of the public are not met. Disclosure of patent working functions as a critical evidentiary foundation for assessing these conditions. Persistent non-disclosure or repeated assertions of non-working without adequate justification may indicate that the patent is being used as a tool of exclusion rather than innovation dissemination. In such circumstances, non-disclosure strengthens the factual basis upon which compulsory licensing applications may be evaluated, as it raises legitimate concerns regarding availability, access, and utilisation of the patented invention. Although failure to disclose does not automatically result in the grant of a compulsory licence, it materially weakens the patentee’s position by exposing the patent to regulatory scrutiny and by facilitating statutory intervention to ensure that the invention serves its intended public and commercial function. Consequently, non-disclosure of patent working operates not merely as a compliance lapse but as a factor capable of directly affecting the scope and durability of patent exclusivity under Indian law.
Recent Regulatory Amendments Affecting Disclosure of Patent Working
The recent amendments relating to Form 27 reflect a deliberate regulatory recalibration of India’s patent disclosure framework. Over time, concerns were raised by patentees and industry stakeholders that the earlier Form 27 regime imposed a disproportionate compliance burden, particularly due to its annual filing requirement and the obligation to disclose sensitive commercial and financial information. These requirements were viewed as excessive in relation to the core objective of monitoring whether patents were being worked in India. The regulatory intent behind the amendment was not to dilute the obligation of disclosure, but to refine its scope so that it remains effective without being unduly intrusive. The legislature recognised that while disclosure of patent working is essential for accountability, compelling disclosure of detailed revenue figures and annual filings could discourage compliance, expose confidential business information, and impose unnecessary administrative costs, especially on patentees holding large patent portfolios. Accordingly, the amended framework simplifies the disclosure mechanism while preserving its statutory purpose. The most significant change introduced is the reduction in filing frequency, whereby Form 27 is now required to be filed once in respect of a block of three financial years, rather than annually. This change reflects a shift from rigid periodic reporting to a more proportionate compliance model, reducing repetitive filings while retaining regulatory oversight. Further, the scope of information required to be disclosed has been streamlined. The amended Form 27 focuses primarily on whether a patented invention has been worked or not worked in India, and, where it has not been worked, the reasons for such non-working. The earlier requirement to furnish detailed quantitative and revenue-based information has been removed, thereby limiting disclosure to information that is directly relevant to assessing patent working, without compelling disclosure of commercially sensitive data. Another notable change is the allowance for consolidated disclosure in appropriate cases, enabling a single Form 27 to cover multiple related patents. This reform acknowledges the practical realities of modern patent portfolios and seeks to reduce procedural complexity without compromising transparency.
Interpretation of Statutory Disclosure Requirements Relating to Patent Working: Judicial Perspective
Shamnad Basheer v. Union of India
This decision marked the judicial examination of compliance with Form 27 disclosure requirements. The petitioner highlighted systemic non-compliance and submission of vague or incomplete disclosures by patentees. The Delhi High Court recognised that disclosure of patent working is a substantive statutory obligation, not a mere procedural formality. It was observed that inadequate reporting undermines transparency and impedes assessment of whether patents are genuinely worked or retained as dormant monopolies. Although no direct sanctions were imposed, the judgment exposed structural deficiencies in compliance and prompted regulatory reconsideration. It established that Form 27 disclosures must be meaningful, accurate, and consistent with the statutory objective of accountability.
Natco Pharma Ltd. v. Bayer Corporation
This case represented the transition from disclosure scrutiny to enforcement. Bayer’s patented anti-cancer drug was neither adequately manufactured in India nor made available at an affordable price. Natco sought and obtained India’s first compulsory licence because the reasonable requirements of the public were unmet and the invention was not sufficiently worked in India. While Form 27 disclosures were not the sole determinant, evidence concerning patent working significantly informed the decision. The ruling underscored that patent exclusivity is conditional and subject to compliance with public interest obligations.
Bayer Corporation v. Union of India
The Bombay High Court upheld the grant of the compulsory licence, rejecting Bayer’s contention that importation constituted sufficient working. The Court affirmed that Indian patent law prioritises accessibility and affordability over absolute proprietary control. It reinforced that patent rights must operate within statutory objectives and cannot be exercised to defeat public welfare, particularly in matters concerning public health.
Key takeaway:
Obtaining a patent grants exclusive rights, but working the invention and maintaining Form 27 compliance is equally important in the Indian patent system.